Pre-made Oral Steroid Liquid Letrozole Femara 5mg/ml

Product Details:

 

Femara 5 Information
Femara 5 Price100mlAccording to your needs
500mlAccording to your needs
1000mlAccording to your needs
Steroid packagingSpecial stealth packaging through Customs
Delivery timeAbout 7 days
ShippingEMS, Hongkong Post, DHL, TNT, Fedex
Payment termsWU, MG, Bitcoin, T/T
Minimum order

100ml liquid

Inquiry

Pre-made Oral Steroid Liquid Letrozole Femara 5mg/ml

 

Oral Letrozole (Femara) 5 Details:

Letrozole CAS: 112809-51-5
Letrozole Molecular Formula: C17H11N5
Letrozole Molecular Weight: 285.31
Letrozole Molecular Specifications:5mg/ml
Letrozole White or light yellow Liquid

Letrozole Usage: Used as API in Treatment of breast disease.
Letrozole is approved by the united states food and drug administration (fda) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.

 

Oral Letrozole (Femara) 5 Specifications:

COA

TestsSpecificationsResults
AppearanceWhite or off-white crystaline powderWhite Crystalline powder
SolubilitySoluble in Chloroform; Soluble in ethanol when heatedConform
ldentification(1)Maximum absorption in wavelength of 240 nm Minimum absorption in wavelength of 215 nmConform Conform
 (2)Infrared spectrum should be in accordance the dominant peak of contrastIn accordance with the dominant peak of contrast
Melting points182ºC-184ºC182ºC
Related substances≤0.5%0.3%
Single impurity≤0.3%0.2%
Loss on drying≤1.0%0.8%
Assay≥98.0%99.2%

 

Oral Letrozole (Femara) 5 Descriptions:

Letrozole is approved by the united states food and drug administration (fda) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.

Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.

Please send your inquiry with DESTINATION,PRODUCT NAMES and QUANTITIES directly to us


Send